This is a DASH proposal that takes action.
https://www.dash.org/forum/threads/pre-proposal-cannabis-genomic-blockchain-on-dash-phase-2.34931/
@A_node_to_a_Master
@TanteStefana
@Name3
@Danny_Somthin
@QuantumExplorer
@TheSingleton
@Chuck Williams
@3d1409ae
@Beru
@Dashmaximalist
@Benglian
@TaoOfSatoshi
@Paris
Cannabis Genomic Blockchain on DASH: Phase II
PROPOSAL DESCRIPTION
Phase II: Sequence the cannabis genome to the fullest extent possible, perform a crypto-bounty peer review and place the Cannabis genome public on DASH Drive.
40 DASH for 6 months. 240 DASH total
Tl:Dr
This is the second part of a previously funded and very popular DASH project: https://www.dashcentral.org/p/MedicinalGenomics
This project has a 1005:102 Yes:No Masternode vote and has been delivering successfully on all goals.
Medicinal Genomics was the first entity to sequence the cannabis genome in 2011 with worldwide news coverage. The technology in 2011 left 100,000 holes in the genome and 7 years later technology has finally advanced to improve the contiguity of the reference sequence 100 fold. This is a significant scientific advancement in the Cannabis field. This will also inform the field regarding recently issued and controversial cannabis patents that are believed to be excessively broad in claim scope and affect affordable access to any plants that produce both CBD and THC.
Cultural movement marketing
I)As Twitter, YouTube, Google and Facebook ban crypto advertisement, one needs to consider alternative and more strategic marketing mechanisms to crack the cannabis market. This proposal enables DASH to be the centerpiece of one of the most important scientific achievements in the Cannabis field. It will catapult DASH as a leader in the field as opposed to a nascent novel entrant to the field. Building the ultimate cannabis genome sequence and hosting this on the DASH drive network will drive DASH awareness amongst the well-funded and most advanced cannabis companies.
II)This novel approach to genomic funding and crypto-peer review will gain the attention of the rapidly growing $20B genomics market and $25B scientific publishing markets.
III)The implications for intellectual property on ephemerally prohibited plants will also be impacted by this proposal. This is topic of increasing concern in the cannabis field as described by GQ magazine and many news outlets.
For more on Cultural Marketing see
https://www.forbes.com/sites/onmark...etitive-advantage-for-marketers/#95723847a13c
https://www.huffingtonpost.com/jure-klepic/how-cultural-marketing-is_b_5815896.html
What is a crypto bounty peer review?
This is a response to the broken peer review system where Publishers have been running a racket for many decades. This racket has the researches hand over copyright of their discoveries to a Publisher who then charges the researchers $3000 per article to publish and charges readers to $50 per article to read the scientific work. Neither the researcher nor the reviewer is compensated for their efforts in the process. This creates a broken incentive model and as a result we have high scientific retraction rates and low reproducibility rates for published papers. By using crypto-incentivized peer review, the process can disintermediate a $25B publishing industry, and deliver faster and more reliable results. These were first experimented with on the Kratom Genome Project and more can be seen at http://raidreviews.org or KratomDNA.org.
Why perform a crypto bounty peer review?
This benefits DASH as it highlights DASH not only bringing truth to ledgers but truth in scientific publishing. This differentiates DASH from other cannabis scam-coins.
Our last proposal organized and incentivized Stampd.io to enable DASH blockchain notarization that we currently use at Kannapedia.net. Strains are now being notarized on DASH instead of Bitcoin. This proposal will expand on this and notarize the new genome reference but also all communication in the crypto-peer review process.
http://www.kannapedia.net/strains/rsp11041/
http://www.kannapedia.net/strains/rsp11051/
http://www.kannapedia.net/strains/rsp11052/
http://www.kannapedia.net/strains/rsp11053/
http://www.kannapedia.net/strains/rsp11054/
Why disrupt 4 overly broad Cannabis patents? No matter where you stand on IP, most people agree that overly broad patent claims stifle the growth of markets. The first issued cannabis patents awarded are excessively broad due to the USPTOs lack of knowledge of the prior art space in a black market. These patents make claims to all CBD+/THC+ plants. By providing a public sequence for growers to compare their pre-patent (2013) strains to, we can build a resource to help substantiate prior art and reduce the scope of these patents.
As a result this project aims to sequence a CBD+/THC+ strain that these patents claim but cannot enforce until federal prohibition ends. The patents don't claim DNA. They claim plants so we are not violating patents by sequencing DNA but we are challenging the ones that exist by making this resource public and enabling growers to challenge these patents with any strains they have that match this sequence and predate the patent dates. This is a freedom play that the cannabis field will cheer on and support.
A few videos on the impact of the recent Cannabis Patents
http://www.thekindland.com/wellness/a-real-thc-scientist-talks-dna-of-weed-and-patenting-1358
Make data available with Creative Commons DASH/NEB/Medicinal Genomics attribution license that captures an email for use of the data. We believe in open source but to prevent spam or excessive download costs, capturing an email can limit spam and enrich for true users of the data. These emails will be very enriched for the most advanced and well funded players in the cannabis industry. This is a more targeted way to capture market/mindshare with Twitter, Google, Youtube and Facebook all banning crypto ads.
Accept further Donations in DASH to annotate the Genome. Once the genome is complete, further annotation and display of the data could be crowd sourced with DASH transactions.
Why Should DASH care? DASH is spending millions to crack into the cannabis industry by sponsoring conferences. For fractions of that sponsorship money, DASH could crack the hardest problem in the cannabis field and be speaking about this at those conferences as opposed to having just a booth.
DASH would be shown to not only solve the monetary issues in the field but also the research funding issues, the peer review and publication issues and the scientific challenges that will be key to seed to sale tracking and the seed verification tools being built around genetics.
This greatly differentiates DASH from potcoin, hempcoin, and a dozen other alt-coins pushing into the cannabis market as DASH would be money, peer review, science, and a publication platform.
DASH is a sponsor of CannMed 2018 (I started this conference at Harvard Med School 2 years ago). This 1500 person conference is the premier scientific conference in the field and we could have this project complete for presentation at that October timeframe.
How are we going to do it?
We have organized this project with various parties that have Skin in the Game. NEB is donating sequencing. Medicinal Genomics is not charging any management or overhead fee for organizing and spearheading such a sizeable project.
The Technical deep dive with Budget:
https://www.medicinalgenomics.com/w...nnabis-genome-on-dash-drive_4_4_2018_tech.pdf